Search results

Scientific Publication

Evaluation of the abuse potential of pitolisant, a selective H3-receptor antagonist/inverse agonist, for the treatment of adult patients with narcolepsy with or without cataplexy

Apr 16, 2020
- Clinical Trials
Press Release

Altasciences Completes Phase I Study on Gimsilumab for ARDS in COVID-19

Mar 27, 2020
Press Release

Altasciences and Amador Bioscience Announce Strategic Collaboration

Mar 17, 2020
ISSUE NO. 12 — Antisense Oligonucleotides

Mar 6, 2020
Early cardiac assessment studies to determine cardiac safety profile

Feb 24, 2020
- Clinical Trials
Answers to your questions on the development of biologics and biosimilars

Jan 24, 2020
Blog

Artificial Intelligence Application in Early Phase Drug Development

Jan 21, 2020

Artificial intelligence, or AI, has been on the radar screen as a possible tool to improve drug development, and clinical trial design and conduct for some time. This month's blog covers some of the advancements.
- Outsourcing Drug Development
- Clinical Trials